查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1708022

全球登革熱檢測市場：產業分析、規模、佔有率、成長、趨勢和預測（2025-2032 年）

Dengue Testing Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025 - 2032
出版日期: | 出版商: Persistence Market Research | 英文 240 Pages | 商品交期: 2-5個工作天內

價格
簡介目錄

預計 2025 年全球登革熱檢測市場規模將達到 5.835 億美元，到 2032 年將達到 8.658 億美元，預測期內（2025-2032 年）的複合年成長率為 5.8%。

登革熱檢測市場包括用於檢測疑似感染個體中是否有登革熱病毒的診斷測試。這些測試有助於確定患者是否患有登革熱，登革熱是由蚊蟲叮咬傳播的登革熱病毒引起的。由於熱帶和亞熱帶地區登革熱發病率的增加、醫療保健意識的增強以及診斷技術的進步，市場正在穩步成長。市面上有各種檢測方法，包括基於 ELISA 的檢測、RT-PCR 檢測和快速登革熱檢測，主要用於醫院、診斷中心和公共衛生實驗室。

登革熱檢測市場的成長主要是由於攜帶病毒的家貓在熱帶和亞熱帶地區流行，導致登革熱發病率不斷上升。全球氣候變遷、都市化和人口流動導致登革熱病例增加，因此快速且準確的診斷至關重要。對登革熱早期發現和管理的需求日益成長，促使醫療機構採用先進的診斷技術。此外，政府控制登革熱疫情和改善醫療保健基礎設施的舉措，以及擴大採用照護現場診斷工具（POC）也是推動市場發展的主要因素。

儘管對登革熱檢測的需求不斷成長，但仍有幾個因素限制市場的成長。診斷測試的成本很高，尤其是在低收入國家，限制了先進測試技術的採用。此外，偏遠和農村地區缺乏基礎設施和訓練有素的人力，阻礙了檢測策略的有效實施。此外，由於檢測方法不同導致的診斷準確性差異，以及檢測可用性和品管問題，也為市場帶來了挑戰。此外，一些地區對早期診斷重要性的認知不足，導致檢測延遲，進而影響整體市場的成長。

由於分子診斷技術（尤其是具有高靈敏度和特異性的 RT-PCR）的進步，登革熱檢測市場提供了巨大的成長機會。實驗室和診斷中心自動化程度的不斷提高為開發更有效率、更快捷的測試解決方案提供了機會。此外，人們對開發能夠檢測多種感染疾病（包括登革熱）的多重診斷試劑套件的興趣日益濃厚，這可能會推動市場擴張。南美洲、拉丁美洲和非洲等登革熱常見地區的新興市場為市場進入者提供了豐厚的機會。增加對公共衛生計劃的投資和開發具有成本效益的測試方案可能會為市場成長提供進一步的機會。

本報告研究了全球登革熱檢測市場，並按產品類型、最終用戶、區域趨勢和參與市場的公司概況進行細分。

目錄

第1章執行摘要

第2章 市場概述

  • 市場範圍和定義
  • 市場動態
  • COVID-19影響分析
  • 預測因子－相關性和影響力

第3章 增值洞察

第4章全球登革熱檢測市場展望

  • 主要亮點
  • 市場規模分析與預測
    • 2019-2024 年歷史市場規模分析
    • 2025-2032年目前市場規模分析與預測
  • 全球登革熱檢測市場展望（依產品類型）
    • 2019 年至 2024 年按產品類型分類的歷史市場規模分析
    • 2025 年至 2032 年按產品類型分類的當前市場規模分析與預測
    • 按產品類型進行市場吸引力分析
  • 全球登革熱檢測市場前景（按最終用戶）
    • 2019 年至 2024 年最終用戶市場規模歷史分析
    • 2025 年至 2032 年按最終用戶分類的當前市場規模分析和預測
    • 最終用戶的市場吸引力分析

5. 全球登革熱檢測市場（按地區）展望

  • 2019 年至 2024 年各地區歷史市場規模分析
  • 2025 年至 2032 年各地區目前市場規模分析與預測
    • 北美洲
    • 拉丁美洲
    • 歐洲
    • 東亞
    • 南亞和大洋洲
    • 中東和非洲
  • 按地區分析市場吸引力

6. 北美登革熱檢測市場展望

7. 歐洲登革熱檢測市場展望

8. 東亞登革熱檢測市場展望

9. 南亞和大洋洲登革熱檢測市場展望

10. 拉丁美洲登革熱檢測市場展望

11.中東和非洲登革熱檢測市場展望

第12章競爭格局

  • 2025年市場佔有率分析
  • 市場結構
  • 公司簡介（詳情－概述、財務狀況、策略、最新發展）
    • Thermo Fisher Scientific Inc.
    • Abnova Corporation
    • Roche Molecular Systems Inc.
    • Abbott Laboratories
    • InBios International, Inc.
    • NovaTec Immundiagnostica GmbH
    • Euroimmun AG（Sub. PerkinElmer）
    • Quest Diagnostics
    • Certest Biotec SL
    • OriGene Technologies
    • Jiangsu BioPerfectus Technologies Co., Ltd
    • Vitrosens Biyoteknoloji A.
    • ACON Biotech（Hangzhou）Co., Ltd.
    • Biozek
    • Mankind Pharma Pvt Ltd
    • Sun Pharmaceutical Industries Ltd
    • 其他

第13章 附錄

簡介目錄
Product Code: PMRREP22738

Persistence Market Research has recently released a comprehensive report on the global Dengue Testing Market, offering an in-depth analysis of key market dynamics, including driving forces, emerging trends, opportunities, and challenges. This report provides a detailed understanding of the market landscape, helping stakeholders make well-informed decisions.

Key Insights:

  • Dengue Testing Market Size (2025E): US$ 583.5 Mn
  • Projected Market Value (2032F): US$ 865.8 Mn
  • Global Market Growth Rate (CAGR 2025 to 2032): 5.8%

Dengue Testing Market - Report Scope:

The Dengue Testing Market includes diagnostic tests used to detect the presence of the dengue virus in individuals suspected of being infected. These tests help determine whether a patient has dengue fever, which is caused by the dengue virus transmitted through mosquito bites. With increasing incidences of dengue in tropical and subtropical regions, along with rising healthcare awareness and advancements in diagnostic technology, the market is experiencing steady growth. The market includes a variety of testing methods such as ELISA-based tests, RT-PCR tests, and dengue rapid tests, which are primarily used in hospitals, diagnostic centers, and public health laboratories.

Market Growth Drivers:

The growth of the Dengue Testing Market is primarily driven by the increasing prevalence of dengue fever in tropical and subtropical regions, where the Aedes mosquitoes that transmit the virus are common. Global climate change, urbanization, and population mobility contribute to the rising number of dengue cases, making rapid and accurate diagnostics crucial. The growing demand for early detection and management of dengue fever is prompting healthcare facilities to adopt advanced diagnostic technologies. Furthermore, government initiatives to control dengue outbreaks and improve healthcare infrastructure, coupled with the rising adoption of point-of-care (POC) diagnostic tools, are key factors driving the market.

Market Restraints:

Despite the growing demand for dengue testing, several factors are restraining market growth. The high cost of diagnostic tests, particularly in low-income countries, limits the widespread adoption of advanced testing technologies. Additionally, the lack of infrastructure and trained personnel in remote and rural areas hampers the effective implementation of testing strategies. The variability in diagnostic accuracy between different testing methods, as well as challenges related to test availability and quality control, also poses challenges for the market. Moreover, limited awareness about the importance of early diagnosis in certain regions contributes to delayed testing, thereby impacting overall market growth.

Market Opportunities:

The Dengue Testing Market presents significant growth opportunities, particularly with advancements in molecular diagnostic techniques like RT-PCR, which offer higher sensitivity and specificity. The growing trend towards automation in laboratories and diagnostic centers presents an opportunity for the development of more efficient and faster testing solutions. Additionally, there is a growing focus on the development of multiplex diagnostic kits capable of detecting multiple infectious diseases, including dengue, which could drive market expansion. Emerging markets in regions like South Asia, Latin America, and Africa, where dengue outbreaks are frequent, provide a lucrative opportunity for market players. Increased investment in public health initiatives and the development of cost-effective testing options will further open up opportunities for market growth.

Key Questions Answered in the Report:

  • What are the primary factors driving the global dengue testing market's growth?
  • Which regions and market segments are experiencing the highest demand for dengue testing?
  • How are innovations in diagnostic technologies influencing market dynamics?
  • Who are the key players in the dengue testing market, and what strategies are they adopting to stay competitive?
  • What are the emerging trends and future projections for the global dengue testing market?

Competitive Intelligence and Business Strategy:

Leading companies in the global dengue testing market, such as Abnova Corporation, Roche Molecular Systems Inc., Abbott Laboratories, InBios International, Inc., and others, are focusing on product innovation, strategic partnerships, and expanding their global presence. These companies are investing in research and development to improve the sensitivity and specificity of dengue tests. They are also exploring opportunities to expand their market reach through partnerships with public health organizations and diagnostic centers. Collaborating with governmental health agencies to provide affordable diagnostic solutions in endemic regions is becoming a key strategic focus to enhance market penetration.

Companies Covered in This Report:

  • Abnova Corporation
  • Roche Molecular Systems Inc.
  • Abbott Laboratories
  • InBios International, Inc.
  • NovaTec Immundiagnostica GmbH
  • Euroimmun AG (Sub. PerkinElmer)
  • Quest Diagnostics
  • Certest Biotec S.L.
  • OriGene Technologies

Dengue Testing Market Segmentation:

By Product Type:

  • ELISA-based Tests
  • RT-PCR based Tests
  • Dengue IgG/IgM Rapid Test
  • Others

By End-User:

  • Hospitals
  • Public Health Laboratories
  • Diagnostic Centers
  • Others

By Region:

  • North America
  • Europe
  • East Asia
  • South Asia and Oceania
  • Latin America
  • Middle East and Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Dengue Testing Market Snapshot, 2025-2032
  • 1.2. Market Opportunity Assessment, 2025-2032, US$ Mn
  • 1.3. Key Market Trends
  • 1.4. Future Market Projections
  • 1.5. Premium Market Insights
  • 1.6. Industry Developments and Key Market Events
  • 1.7. PMR Analysis and Recommendations

2. Market Overview

  • 2.1. Market Scope and Definition
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Opportunity
    • 2.2.4. Challenges
    • 2.2.5. Key Trends
  • 2.3. COVID-19 Impact Analysis
  • 2.4. Forecast Factors - Relevance and Impact

3. Value Added Insights

  • 3.1. Value Chain Analysis
  • 3.2. Technology Adoption / Usage Analysis
  • 3.3. Diseases Epidemiology
  • 3.4. Key Market Players
  • 3.5. Regulatory Landscape
  • 3.6. PESTLE Analysis
  • 3.7. Porter's Five Forces Analysis
  • 3.8. Consumer Behavior Analysis

4. Global Dengue Testing Market Outlook

  • 4.1. Key Highlights
    • 4.1.1. Market Size (US$ Mn) and Y-o-Y Growth
    • 4.1.2. Absolute $ Opportunity
  • 4.2. Market Size (US$ Mn) Analysis and Forecast
    • 4.2.1. Historical Market Size (US$ Mn) Analysis, 2019-2024
    • 4.2.2. Current Market Size (US$ Mn) Analysis and Forecast, 2025-2032
  • 4.3. Global Dengue Testing Market Outlook: Product Type
    • 4.3.1. Historical Market Size (US$ Mn) Analysis, By Product Type, 2019-2024
    • 4.3.2. Current Market Size (US$ Mn) Analysis and Forecast, By Product Type, 2025-2032
      • 4.3.2.1. ELISA-based Tests
      • 4.3.2.2. RT-PCR based Tests
      • 4.3.2.3. Dengue IgG/IgM Rapid Test
      • 4.3.2.4. Others
    • 4.3.3. Market Attractiveness Analysis: Technology
  • 4.4. Global Dengue Testing Market Outlook: End-User
    • 4.4.1. Historical Market Size (US$ Mn) Analysis, By End-User, 2019-2024
    • 4.4.2. Current Market Size (US$ Mn) Analysis and Forecast, By End-User, 2025-2032
      • 4.4.2.1. Hospitals
      • 4.4.2.2. Public Health Laboratory
      • 4.4.2.3. Diagnostic Centers
      • 4.4.2.4. Others
    • 4.4.3. Market Attractiveness Analysis: End-User

5. Global Dengue Testing Market Outlook Region

  • 5.1. Historical Market Size (US$ Mn) Analysis, By Region, 2019-2024
  • 5.2. Current Market Size (US$ Mn) Analysis and Forecast by Region, 2025-2032
    • 5.2.1. North America
    • 5.2.2. Latin America
    • 5.2.3. Europe
    • 5.2.4. East Asia
    • 5.2.5. South Asia and Oceania
    • 5.2.6. Middle East & Africa
  • 5.3. Market Attractiveness Analysis: Region

6. North America Dengue Testing Market Outlook

  • 6.1. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
    • 6.1.1. By Country
    • 6.1.2. By Product Type
    • 6.1.3. By End-User
  • 6.2. Current Market Size (US$ Mn) Analysis and Forecast by Country, 2025-2032
    • 6.2.1. U.S.
    • 6.2.2. Canada
  • 6.3. Current Market Size (US$ Mn) Analysis and Forecast by Product Type, 2025-2032
    • 6.3.1. ELISA-based Tests
    • 6.3.2. RT-PCR based Tests
    • 6.3.3. Dengue IgG/IgM Rapid Test
    • 6.3.4. Others
  • 6.4. Current Market Size (US$ Mn) Analysis and Forecast, by End-User, 2025-2032
    • 6.4.1. Hospitals
    • 6.4.2. Public Health Laboratory
    • 6.4.3. Diagnostic Centers
    • 6.4.4. Others
  • 6.5. Market Attractiveness Analysis

7. Europe Dengue Testing Market Outlook

  • 7.1. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
    • 7.1.1. By Country
    • 7.1.2. By Product Type
    • 7.1.3. By End-User
  • 7.2. Current Market Size (US$ Mn) Analysis and Forecast by Country, 2025-2032
    • 7.2.1. Germany
    • 7.2.2. France
    • 7.2.3. U.K.
    • 7.2.4. Italy
    • 7.2.5. Spain
    • 7.2.6. Russia
    • 7.2.7. Rest of Europe
  • 7.3. Current Market Size (US$ Mn) Analysis and Forecast by Product Type, 2025-2032
    • 7.3.1. ELISA-based Tests
    • 7.3.2. RT-PCR based Tests
    • 7.3.3. Dengue IgG/IgM Rapid Test
    • 7.3.4. Others
  • 7.4. Current Market Size (US$ Mn) Analysis and Forecast, by End-User, 2025-2032
    • 7.4.1. Hospitals
    • 7.4.2. Public Health Laboratory
    • 7.4.3. Diagnostic Centers
    • 7.4.4. Others
  • 7.5. Market Attractiveness Analysis

8. East Asia Dengue Testing Market Outlook

  • 8.1. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
    • 8.1.1. By Country
    • 8.1.2. By Product Type
    • 8.1.3. By End-User
  • 8.2. Current Market Size (US$ Mn) Analysis and Forecast by Country, 2025-2032
    • 8.2.1. China
    • 8.2.2. Japan
    • 8.2.3. South Korea
  • 8.3. Current Market Size (US$ Mn) Analysis and Forecast by Product Type, 2025-2032
    • 8.3.1. ELISA-based Tests
    • 8.3.2. RT-PCR based Tests
    • 8.3.3. Dengue IgG/IgM Rapid Test
    • 8.3.4. Others
  • 8.4. Current Market Size (US$ Mn) Analysis and Forecast, by End-User, 2025-2032
    • 8.4.1. Hospitals
    • 8.4.2. Public Health Laboratory
    • 8.4.3. Diagnostic Centers
    • 8.4.4. Others
  • 8.5. Market Attractiveness Analysis

9. South Asia & Oceania Dengue Testing Market Outlook

  • 9.1. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
    • 9.1.1. By Country
    • 9.1.2. By Product Type
    • 9.1.3. By End-User
  • 9.2. Current Market Size (US$ Mn) Analysis and Forecast by Country, 2025-2032
    • 9.2.1. India
    • 9.2.2. Indonesia
    • 9.2.3. Thailand
    • 9.2.4. Singapore
    • 9.2.5. ANZ
    • 9.2.6. Rest of South Asia & Oceania
  • 9.3. Current Market Size (US$ Mn) Analysis and Forecast by Product Type, 2025-2032
    • 9.3.1. ELISA-based Tests
    • 9.3.2. RT-PCR based Tests
    • 9.3.3. Dengue IgG/IgM Rapid Test
    • 9.3.4. Others
  • 9.4. Current Market Size (US$ Mn) Analysis and Forecast, by End-User, 2025-2032
    • 9.4.1. Hospitals
    • 9.4.2. Public Health Laboratory
    • 9.4.3. Diagnostic Centers
    • 9.4.4. Others
  • 9.5. Market Attractiveness Analysis

10. Latin America Dengue Testing Market Outlook

  • 10.1. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
    • 10.1.1. By Country
    • 10.1.2. By Product Type
    • 10.1.3. By End-User
  • 10.2. Current Market Size (US$ Mn) Analysis and Forecast by Country, 2025-2032
    • 10.2.1. Brazil
    • 10.2.2. Mexico
    • 10.2.3. Rest of Latin America
  • 10.3. Current Market Size (US$ Mn) Analysis and Forecast by Product Type, 2025-2032
    • 10.3.1. ELISA-based Tests
    • 10.3.2. RT-PCR based Tests
    • 10.3.3. Dengue IgG/IgM Rapid Test
    • 10.3.4. Others
  • 10.4. Current Market Size (US$ Mn) Analysis and Forecast, by End-User, 2025-2032
    • 10.4.1. Hospitals
    • 10.4.2. Public Health Laboratory
    • 10.4.3. Diagnostic Centers
    • 10.4.4. Others
  • 10.5. Market Attractiveness Analysis

11. Middle East & Africa Dengue Testing Market Outlook

  • 11.1. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
    • 11.1.1. By Country
    • 11.1.2. By Product Type
    • 11.1.3. By End-User
  • 11.2. Current Market Size (US$ Mn) Analysis and Forecast by Country, 2025-2032
    • 11.2.1. GCC Countries
    • 11.2.2. Egypt
    • 11.2.3. South Africa
    • 11.2.4. Northern Africa
    • 11.2.5. Rest of Middle East & Africa
  • 11.3. Current Market Size (US$ Mn) Analysis and Forecast by Product Type, 2025-2032
    • 11.3.1. ELISA-based Tests
    • 11.3.2. RT-PCR based Tests
    • 11.3.3. Dengue IgG/IgM Rapid Test
    • 11.3.4. Others
  • 11.4. Current Market Size (US$ Mn) Analysis and Forecast, by End-User, 2025-2032
    • 11.4.1. Hospitals
    • 11.4.2. Public Health Laboratory
    • 11.4.3. Diagnostic Centers
    • 11.4.4. Others
  • 11.5. Market Attractiveness Analysis

12. Competition Landscape

  • 12.1. Market Share Analysis, 2025
  • 12.2. Market Structure
    • 12.2.1. Competition Intensity Mapping by Market
    • 12.2.2. Competition Dashboard
  • 12.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
    • 12.3.1. Thermo Fisher Scientific Inc.
      • 12.3.1.1. Overview
      • 12.3.1.2. Segments and Sources
      • 12.3.1.3. Key Financials
      • 12.3.1.4. Market Developments
      • 12.3.1.5. Market Strategy
    • 12.3.2. Abnova Corporation
    • 12.3.3. Roche Molecular Systems Inc.
    • 12.3.4. Abbott Laboratories
    • 12.3.5. InBios International, Inc.
    • 12.3.6. NovaTec Immundiagnostica GmbH
    • 12.3.7. Euroimmun AG (Sub. PerkinElmer)
    • 12.3.8. Quest Diagnostics
    • 12.3.9. Certest Biotec S.L.
    • 12.3.10. OriGene Technologies
    • 12.3.11. Jiangsu BioPerfectus Technologies Co., Ltd
    • 12.3.12. Vitrosens Biyoteknoloji A.
    • 12.3.13. ACON Biotech (Hangzhou) Co., Ltd.
    • 12.3.14. Biozek
    • 12.3.15. Mankind Pharma Pvt Ltd
    • 12.3.16. Sun Pharmaceutical Industries Ltd
    • 12.3.17. Others

13. Appendix

  • 13.1. Research Methodology
  • 13.2. Research Assumptions
  • 13.3. Acronyms and Abbreviations